학술논문
'학술논문'
에서 검색결과 226건 | 목록
1~10
Academic Journal
Bockermann R; Hansa Biopharma AB, Lund, Sweden.; Järnum S; Hansa Biopharma AB, Lund, Sweden.; Runström A; Hansa Biopharma AB, Lund, Sweden.; Lorant T; Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University, Uppsala, Sweden.; Winstedt L; Hansa Biopharma AB, Lund, Sweden.; Palmqvist N; Hansa Biopharma AB, Lund, Sweden.; Kjellman C; Hansa Biopharma AB, Lund, Sweden.
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6080 (Electronic) Linking ISSN: 00411337 NLM ISO Abbreviation: Transplantation Subsets: MEDLINE
Academic Journal
Rannem T; Hylander E; Ladefoged K; Staun M; Tjellesen L; Jarnum S; Rannem, T; Hylander, E; Ladefoged, K; Staun, M; Tjellesen, L; Jarnum, S
JPEN Journal of Parenteral & Enteral Nutrition; Nov1996, Vol. 20 Issue 6, p412-416, 5p
Report
Stubbs MJ; University College London Haemostasis Research Unit, London, UK.; University College London Hospital, London, UK.; Thomas M; University College London Hospital, London, UK.; Vendramin C; University College London Haemostasis Research Unit, London, UK.; Sonesson E; Hansa Medical AB, Lund, Sweden.; Kjellman C; Hansa Medical AB, Lund, Sweden.; Järnum S; Hansa Medical AB, Lund, Sweden.; Stenberg Y; Hansa Medical AB, Lund, Sweden.; Elfving C; Hansa Medical AB, Lund, Sweden.; Scully M; University College London Haemostasis Research Unit, London, UK.; University College London Hospital, London, UK.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Lorant T; Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University, Uppsala, Sweden.; Bengtsson M; Department of Immunology, Genetics and Pathology, Section of Clinical Immunology, Uppsala University, Uppsala, Sweden.; Eich T; Department of Immunology, Genetics and Pathology, Section of Clinical Immunology, Uppsala University, Uppsala, Sweden.; Eriksson BM; Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden.; Winstedt L; Hansa Medical AB, Lund, Sweden.; Järnum S; Hansa Medical AB, Lund, Sweden.; Stenberg Y; Hansa Medical AB, Lund, Sweden.; Robertson AK; Hansa Medical AB, Lund, Sweden.; Mosén K; Hansa Medical AB, Lund, Sweden.; Björck L; Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden.; Bäckman L; Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University, Uppsala, Sweden.; Larsson E; Department of Immunology, Genetics and Pathology, Section of Molecular and Morphological Pathology, Uppsala University, Uppsala, Sweden.; Wood K; Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.; Tufveson G; Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University, Uppsala, Sweden.; Kjellman C; Hansa Medical AB, Lund, Sweden.
Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE
Academic Journal
Karlsson CAQ; From the ‡Lund University, Division of Infection Medicine, Department of Clinical Sciences, Solvegatan 19, BMC, Lund, 221 84 Lund, Sweden.; Järnum S; §Hansa Medical AB, Scheelevägen 22, 223 63 Lund, Sweden.; Winstedt L; §Hansa Medical AB, Scheelevägen 22, 223 63 Lund, Sweden.; Kjellman C; §Hansa Medical AB, Scheelevägen 22, 223 63 Lund, Sweden.; Björck L; From the ‡Lund University, Division of Infection Medicine, Department of Clinical Sciences, Solvegatan 19, BMC, Lund, 221 84 Lund, Sweden.; Linder A; From the ‡Lund University, Division of Infection Medicine, Department of Clinical Sciences, Solvegatan 19, BMC, Lund, 221 84 Lund, Sweden.; Malmström JA; From the ‡Lund University, Division of Infection Medicine, Department of Clinical Sciences, Solvegatan 19, BMC, Lund, 221 84 Lund, Sweden; johan.malmstrom@med.lu.se.
Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE
The effect of selenium supplementation on skeletal and cardiac muscle in selenium-depleted patients.
Academic Journal
Rannem T; Ladefogen K; Hylander E; Christiansen J; Laursen H; Kristensen H; Linstow M; Beyer N; Liguori R; Dige-Petersen H; Jensen BH; Jarnum S; Rannem, T; Ladefoged, K; Hylander, E; Christiansen, J; Laursen, H; Kristensen, J H; Linstow, M; Beyer, N; et al
Academic Journal
Järnum S; Hansa Medical AB, Lund, Sweden.; Runström A; Hansa Medical AB, Lund, Sweden.; Bockermann R; Hansa Medical AB, Lund, Sweden.; Winstedt L; Hansa Medical AB, Lund, Sweden.; Crispin M; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom. christian.kjellman@hansamedical.com max.crispin@bioch.ox.ac.uk.; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California.; Kjellman C; Hansa Medical AB, Lund, Sweden. christian.kjellman@hansamedical.com max.crispin@bioch.ox.ac.uk.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Jordan SC; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Lorant T; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Choi J; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Kjellman C; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Winstedt L; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Bengtsson M; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Zhang X; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Eich T; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Toyoda M; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Eriksson BM; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Ge S; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Peng A; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Järnum S; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Wood KJ; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Lundgren T; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Wennberg L; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Bäckman L; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Larsson E; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Villicana R; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Kahwaji J; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Louie S; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Kang A; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Haas M; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Nast C; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Vo A; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).; Tufveson G; From the Comprehensive Transplant Center (S.C.J., J.C., M.T., S.G., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunotherapy Program (S.C.J., J.C., A.P., R.V., J.K., S.L., A.K., A.V.), Transplant Immunology Laboratory (S.C.J., M.T., S.G.), HLA Laboratory (X.Z.), and the Department of Pathology (M.H., C.N.), Cedars-Sinai Medical Center, Los Angeles; the Section of Transplantation Surgery, Department of Surgical Sciences (T. Lorant, L.B., G.T.), the Section of Molecular and Morphological Pathology (M.B., E.L.) and the Section of Clinical Immunology (T.E.), Department of Immunology, Genetics, and Pathology, and the Section of Infectious Diseases, Department of Medical Sciences (B.-M.E.), Uppsala University, Uppsala, Hansa Medical, Lund (C.K., L. Winstedt, S.J.), and the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, and the Department of Transplantation Surgery, Karolinska University Hospital, Stockholm (T. Lundgren, L. Wennberg) - all in Sweden; and the Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom (K.J.W.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Wang Y; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China; Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Shi Q; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Lv H; Graduate School of Tianjin Medical University, Tianjin 300071, People's Republic of China.; Hu M; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Wang W; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Wang Q; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Qiao B; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Zhang G; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Lv Z; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Kjellman C; Hansa Medical AB, Lund, Sweden.; Järnum S; Hansa Medical AB, Lund, Sweden.; Winstedt L; Hansa Medical AB, Lund, Sweden.; Zhang Y; Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, People's Republic of China.; Wen J; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China.; Hao Y; Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, People's Republic of China. Electronic address: yanleihao301@live.com.; Yuki N; Department of Neurology, Mishima Hospital, Niigata, Japan. Electronic address: gbs.yuki.cidp@gmail.com.
Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2430 (Electronic) Linking ISSN: 00144886 NLM ISO Abbreviation: Exp Neurol Subsets: MEDLINE
Academic Journal
Safavi S; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Järnum S; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Vannas C; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Udhane S; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Jonasson E; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Tomic TT; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Grundevik P; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Fagman H; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Hansson M; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Kalender Z; Mathematical Statistics, Mathematical Sciences, Chalmers University of Technology and the University of Gothenburg, Göteborg, Sweden.; Jauhiainen A; Mathematical Statistics, Mathematical Sciences, Chalmers University of Technology and the University of Gothenburg, Göteborg, Sweden.; Dolatabadi S; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Stratford EW; Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Nydalen, Oslo, Norway.; Myklebost O; Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Nydalen, Oslo, Norway.; Eriksson M; Department of Oncology, Lund University Hospital, Lund, Sweden.; Stenman G; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Schneider-Stock R; Experimental Tumor Pathology, Institute of Pathology, University of Erlangen-Nürnberg, Ulmenweg Erlangen, Germany.; Ståhlberg A; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Åman P; Sahlgrenska Cancer Center, Institute of Biomedicine, Department of Pathology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Jarnum S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어